Live Science on MSN6 小时
Simple blood tests could be the future of cancer diagnosis
Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in ...